These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 16511414

  • 1. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L.
    AIDS; 2006 Jan 09; 20(2):217-22. PubMed ID: 16511414
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.
    Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
    Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M.
    J Infect Dis; 2005 Sep 01; 192(5):720-7. PubMed ID: 16088821
    [Abstract] [Full Text] [Related]

  • 4. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 5. Single-dose Nevirapine during pregnancy.
    Sax PE.
    AIDS Clin Care; 1999 Oct 01; 11(10):84-5. PubMed ID: 11366708
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.
    Clin Infect Dis; 2009 Jul 15; 49(2):299-305. PubMed ID: 19522656
    [Abstract] [Full Text] [Related]

  • 7. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
    Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY.
    Antivir Ther; 2004 Apr 15; 9(2):179-85. PubMed ID: 15134179
    [Abstract] [Full Text] [Related]

  • 8. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.
    Lancet; 2003 Sep 13; 362(9387):859-68. PubMed ID: 13678973
    [Abstract] [Full Text] [Related]

  • 9. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 10. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.
    AIDS; 2009 Apr 27; 23(7):825-33. PubMed ID: 19307941
    [Abstract] [Full Text] [Related]

  • 11. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
    Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M.
    AIDS; 2006 Jun 12; 20(9):1281-8. PubMed ID: 16816557
    [Abstract] [Full Text] [Related]

  • 12. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
    Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA.
    AIDS; 2009 Apr 27; 23(7):809-16. PubMed ID: 19287298
    [Abstract] [Full Text] [Related]

  • 13. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
    Mugabo P, Els I, Smith J, Rabie H, Smith P, Mirochnick M, Steyn W, Hall D, Madsen R, Cotton MF.
    S Afr Med J; 2011 Sep 05; 101(9):655-8. PubMed ID: 21920159
    [Abstract] [Full Text] [Related]

  • 14. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.
    Am J Obstet Gynecol; 2007 Sep 05; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [Abstract] [Full Text] [Related]

  • 15. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
    Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB.
    J Infect Dis; 2001 Oct 01; 184(7):914-7. PubMed ID: 11509999
    [Abstract] [Full Text] [Related]

  • 16. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH, Jackson JB.
    AIDS Rev; 2002 Oct 01; 4(2):59-63. PubMed ID: 12152519
    [Abstract] [Full Text] [Related]

  • 17. Study offers hope for Africa's next generation.
    WORLD; 1999 Sep 01; (No 101):4-5. PubMed ID: 11366948
    [Abstract] [Full Text] [Related]

  • 18. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
    Ekouevi DK, Touré R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F, Agence Nationale de Recherches Sur le SIDA 1201/1202 Ditrame Plus Study Group.
    Pediatrics; 2006 Oct 01; 118(4):e1071-7. PubMed ID: 16950945
    [Abstract] [Full Text] [Related]

  • 19. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening.
    Rollins N, Little K, Mzolo S, Horwood C, Newell ML.
    AIDS; 2007 Jun 19; 21(10):1341-7. PubMed ID: 17545711
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 19; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.